Advertisement

Topics

FDA OKs Pfizer drug for rare, fast-killing type of leukemia

19:32 EDT 17 Aug 2017 | Topix

In this Monday, Nov. 23, 2015, file photo, a Pfizer flag is displayed in front of the company's world headquarters in New York. The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed.

Original Article: FDA OKs Pfizer drug for rare, fast-killing type of leukemia

NEXT ARTICLE

More From BioPortfolio on "FDA OKs Pfizer drug for rare, fast-killing type of leukemia"

Advertisement
Quick Search
Advertisement
Advertisement